Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

EU Commission shortlists ex-Monsanto employee for EFSA Management Board

The European Commission has recommended that one of Europe's chief food lobbyists – who is also a former Monsanto employee – sits on the management board of the European Food Safety Authority (EFSA). Testbiotech and Corporate Europe Observatory say that the appointment of Mella Frewen, lobby chief at FoodDrinkEurope (previously known as the CIAA) will create a conflict of interests for the food agency's management board.

Frewen has been the chief lobbyist at the food industry lobby group since 2007 where she actively lobbied to allow contamination of the food chain with genetically engineered plants which were not authorised in Europe. Christoph Then from Testbiotech said: “Appointing a food lobbyist with a past history of lobbying to allow contamination with genetically engineered plants would seriously undermine public trust in the European Food Safety Authority. There is simply no justification to have industry lobbyists on the board of EFSA.”

Another candidate selected by the Commission, Jiri Ruprich, is already a member of EFSAs Management Board despite having worked with the Czech Danone Institute´s scientific committee for more than 10 years. The list, brought to the attention of Corporate Europe Observatory (CEO) and Testbiotech, contains 14 names, seven of whom will be selected to serve a term on the Management Board. This means that half of the members of the management board will be replaced. The EU Council will make a final decision on the appointments in the next few months.

This week EFSA published details of how it would implement its new policy on conflicts of interest – including an improved definition of “conflicts of interest”, but tougher action is needed, including fundamental changes to EFSA's founding regulations,which are due for review later this year. Nina Holland from Corporate Europe Observatory said: “The regulation should be revised to ban industry lobbyists from EFSA’s management. Instead, there should be more representatives from consumer and also environmental organisations on the board.”

Some of the previous members of the Management Board have come under attack for conflicts of interest, especially its chair, Diana Banati. The new board members will be installed in the next few months. Research by CEO showed that individuals linked to industry occupied four places on the current management board [ref1]. The management board plays an important role in EFSA, approving its working program and deciding which scientists are selected for the expert panels. The Board is also crucial for establishing internal rules on conflicts of interest at the Authority.

Contact: 

Christoph Then, Testbiotech, info@testbiotech.org, Tel. 015154638040, www.testbiotech.org

Nina Holland, Corporate Europe Observatory (CEO), ceonina@corporateeurope.org, Tel. +32 (0)2 893 0930, Mobile: +31 (0) 6 302 85 042 , www.corporateeurope.org

Related issues: 
 

More than 80 per cent of the national experts involved in the EU's official assessment of glyphosate refused to have their names disclosed to the public.

Monsanto and the pesticide industry breathed a collective sigh of relief on 12 November 2015. The findings of an investigation into the toxicity of glyphosate by the European Food Safety Authority (EFSA) and EU Member States were in stark contradiction to the March 2015 conclusion by the International Agency for Research against Cancer (IARC), a body of the World Health Organization (WHO), that this agricultural herbicide was probably causing cancer to humans. If validated, this conclusion could cause a partial ban of glyphosate in the EU. [UPDATED on 30 11 2015 16.30 CET]

Open letter to Commissioner Andriukaitis on glyphosate

Heard by the European Parliament's Committee on the Environment, Public Health and Food Safety, Bernhard Url, EFSA's director, said that the EU had "enough scientific capability around [...] without a chief scientific adviser".

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

The voice of the Dutch Government has been loud and clear in Brussels on the issue of cisgenic plants. The Dutch have waged a sustained campaign to have new GM techniques – and in particular cisgenesis – excluded from EU GMO regulations. Several Dutch ministries, the Dutch Parliament, the Dutch Permanent Representation in Brussels, and Dutch MEPs have energetically pursued this goal.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.

The corporate lobby tour

Stop the Crop

Alternative Trade Mandate